<DOC>
	<DOCNO>NCT00987792</DOCNO>
	<brief_summary>The aim study obtain data hospitalize Community Acquired Pneumonia ( CAP ) patient disease include disease severity , clinical sign symptom measure use diagnosis daily routine practice well data Avelox® include information use , effectiveness , treatment outcome , safety tolerability . As non-interventional observational study , routine clinical practice observe . The application medication follow normal routine decide treat physician recognition package insert .</brief_summary>
	<brief_title>CAPRIVI : Community Acquired Pneumonia : Treatment With Avelox® Hospitalized Patients</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Adult hospitalize patient diagnosis CAP ( base local medical practice ) decision take investigator treat moxifloxacin start treatment intravenous administration . The local moxifloxacin product information must consider . Contraindications state local moxifloxacin product information ; warning precaution must consider .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Community Acquired Pneumonia</keyword>
</DOC>